BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 21865693)

  • 21. microRNA-630 Regulates Underglycosylated IgA1 Production in the Tonsils by Targeting TLR4 in IgA Nephropathy.
    Liu C; Ye MY; Yan WZ; Peng XF; He LY; Peng YM
    Front Immunol; 2020; 11():563699. PubMed ID: 33324395
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum under-galactosylated IgA1 is increased in Japanese patients with IgA nephropathy.
    Shimozato S; Hiki Y; Odani H; Takahashi K; Yamamoto K; Sugiyama S
    Nephrol Dial Transplant; 2008 Jun; 23(6):1931-9. PubMed ID: 18178603
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Downregulation of the beta1,3- galactosyltransferase gene in tonsillar B lymphocytes and aberrant lectin bindings to tonsillar IgA as a pathogenesis of IgA nephropathy.
    Inoue T; Sugiyama H; Kikumoto Y; Fukuoka N; Maeshima Y; Hattori H; Fukushima K; Nishizaki K; Hiki Y; Makino H
    Contrib Nephrol; 2007; 157():120-4. PubMed ID: 17495448
    [TBL] [Abstract][Full Text] [Related]  

  • 24. O-glycosylation of serum IgA1 antibodies against mucosal and systemic antigens in IgA nephropathy.
    Smith AC; Molyneux K; Feehally J; Barratt J
    J Am Soc Nephrol; 2006 Dec; 17(12):3520-8. PubMed ID: 17093066
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The pathogenic role of IgA1 O-linked glycosylation in the pathogenesis of IgA nephropathy.
    Barratt J; Smith AC; Feehally J
    Nephrology (Carlton); 2007 Jun; 12(3):275-84. PubMed ID: 17498123
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathogenetic significance of aberrant glycosylation of IgA1 in IgA nephropathy.
    Narita I; Gejyo F
    Clin Exp Nephrol; 2008 Oct; 12(5):332-338. PubMed ID: 18404247
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of CD19(+)CD5(+)B cells and IgA1-positive cells in tonsillar tissues of IgA nephropathy patients.
    Wu G; Peng YM; Liu H; Hou QD; Liu FY; Chen NL; Bi HX
    Ren Fail; 2011; 33(2):159-63. PubMed ID: 21332337
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Binding capacity and pathophysiological effects of IgA1 from patients with IgA nephropathy on human glomerular mesangial cells.
    Wang Y; Zhao MH; Zhang YK; Li XM; Wang HY
    Clin Exp Immunol; 2004 Apr; 136(1):168-75. PubMed ID: 15030528
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mass spectrometry analysis of IgA1 hinge region in patients with IgA nephropathy.
    Gastaldi D; Paradisi L; Baiocchi C; Medana C; Lo Duca G; Sena LM; Roccatello D
    J Nephrol; 2007; 20(6):689-95. PubMed ID: 18046671
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [IgA1 aberrant glycosylation in the pathogenesis of IgA nephropathy: an overivew].
    Xie L; Wang L; Huang J; Fan J
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2010 Feb; 27(1):227-30. PubMed ID: 20337060
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Mesangial proliferative glomerulonephritis].
    Yamada A
    Nihon Rinsho; 2004 Oct; 62(10):1842-6. PubMed ID: 15500128
    [TBL] [Abstract][Full Text] [Related]  

  • 32.
    Dotz V; Visconti A; Lomax-Browne HJ; Clerc F; Hipgrave Ederveen AL; Medjeral-Thomas NR; Cook HT; Pickering MC; Wuhrer M; Falchi M
    J Am Soc Nephrol; 2021 Oct; 32(10):2455-2465. PubMed ID: 34127537
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Different glycosylation profile of serum IgA1 in IgA nephropathy according to the glomerular basement membrane thickness: normal versus thin.
    Linossier MT; Palle S; Berthoux F
    Am J Kidney Dis; 2003 Mar; 41(3):558-64. PubMed ID: 12612978
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IgA production and tonsillar focal infection in IgA nephropathy.
    Meng H; Ohtake H; Ishida A; Ohta N; Kakehata S; Yamakawa M
    J Clin Exp Hematop; 2012; 52(3):161-70. PubMed ID: 23269075
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reactivity of glomerular and serum IgA1 to jacalin in IgA nephropathy.
    Hiki Y; Iwase H; Saitoh M; Saitoh Y; Horii A; Hotta K; Kobayashi Y
    Nephron; 1996; 72(3):429-35. PubMed ID: 8852492
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Binding of IgA1 to monocyte/macrophage cell lines (THP-1, U937) in IgA nephropathy--a possible role of O-glycan in the IgA1 molecule].
    Horii A; Hiki Y; Saitoh M; Kanamori A; Iwase H; Hotta K; Kobayashi Y
    Nihon Jinzo Gakkai Shi; 1995 Oct; 37(10):558-63. PubMed ID: 7474508
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of alpha(beta)-N-acetyl-D-galactosamine-binding sites in kidney--relation to Henoch-Schönlein-associated IgA nephropathy.
    Sedivá A; Stejskal J; Bartůnková J; Smetana K; Gabius HJ
    Folia Biol (Praha); 1999; 45(4):147-50. PubMed ID: 10732728
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Difference in IgA1 O-glycosylation between IgA deposition donors and IgA nephropathy recipients.
    Nakazawa S; Imamura R; Kawamura M; Kato T; Abe T; Namba T; Iwatani H; Yamanaka K; Uemura M; Kishikawa H; Nishimura K; Oka K; Tajiri M; Wada Y; Nonomura N
    Biochem Biophys Res Commun; 2019 Jan; 508(4):1106-1112. PubMed ID: 30553446
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Direct evidence of the production of IgA by tonsillar lymphocytes and the binding of IgA to the glomerular mesangium of IgA nephropathy patients.
    Tokuda M; Shimizu J; Sugiyama N; Kiryu T; Matsuoka K; Sasaki O; Fukuda K; Hatase O; Monden H
    Acta Otolaryngol Suppl; 1996; 523():182-4. PubMed ID: 9082776
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decreased CD4+CD25+ cells and increased dimeric IgA-producing cells in tonsils in IgA nephropathy.
    Huang H; Peng Y; Liu H; Yang X; Liu F
    J Nephrol; 2010; 23(2):202-9. PubMed ID: 20213609
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.